Myovant Sciences
Brisbane, CA
Myovant Sciences Ltd. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing and commercializing innovative therapies for women's health diseases and other endocrine-related disorders. Myovant Sciences develops relugolix for the treatment of heavy menstrual bleeding associated with uterine fibroids and endometriosis-associated pain.
myovant.comCompany Details
Founded
- 2016
Employees
- Between 407 - 1,000 employees
Raised
- $540,000,000
Headquarters Location
- Brisbane, CA
Public
- Yes
Acquired
- Yes
CEO
- N/A
Founders
- Lynn Seely
Company Collections
These are collections Myovant Sciences is a part of. Click on the collection name to view similar companies.